Tae Matsumoto

Successful gene therapy in utero for lethal murine hypophosphatasia.

J. Millán, M. Migita, T. Shimada, 2012, Human gene therapy.

Treatment with bone maturation and average lifespan of HPP model mice by AAV8-mediated neonatal gene therapy via single muscle injection

J. Millán, N. Miyake, T. Shimada, 2021, Molecular therapy. Methods & clinical development.

Cholelithiasis in a patient with type 2 Gaucher disease.

A. Yamataka, M. Migita, T. Ueda, 2014, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

Renal Biopsy-induced Hematoma and Infection in a Patient with Asymptomatic 2 May-Hegglin Anomaly 3 4 Running title : Asymptomatic May-Hegglin Anomaly

Terasaki, A. Shimizu, K. Nagahama, 2021 .

Transient cardiomyopathy in a patient with congenital contractural arachnodactyly (Beals syndrome).

J. Hayakawa, M. Migita, T. Shimada, 2006, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

Prolonged Survival and Phenotypic Correction of Akp2−/− Hypophosphatasia Mice by Lentiviral Gene Therapy

J. Millán, T. Shimada, T. Maeda, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Somatic mosaicism in MYH9 disorders: the need to carefully evaluate apparently healthy parents

H. Saito, S. Kunishima, T. Sekine, 2014, British journal of haematology.

Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase.

J. Millán, N. Miyake, T. Shimada, 2011, Human gene therapy.

Genetic diagnosis of Werdnig-Hoffmann disease: a problem for application to prenatal diagnosis.

J. Hayakawa, M. Migita, T. Shimada, 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.